More articles from Radiopharmaceutical Therapy Posters

You have access
Size effect on tumor treatment with PEGylated liposomal drugs in a tumor-bearing mouse model
Yi-Yu Lin, Jia-Je Li, Mao-Chi Weng, Jeng-Jong Hwang, Yun-Long Tseng, Ming-Hsien Lin, Wuu-Jyh Lin, Gann Ting and Hsin-Ell Wang

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1737;
You have access
Metastasis after mTOR inhibition by RAD001 in a neuroendocrine rat tumor model: Combination therapy with ¹⁷⁷Lu-DOTA,Tyr₃-octreotate
Stefan Pool, Stuart Koelewijn, Eric Krenning and Marion de Jong

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1746;
You have access
Survival predictors of intraperitoneal radioimmunotherapy for ovarian cancer
Ruby Meredith, Shouluan Ding, Ronald Alvarez, Edward Partridge and Albert LoBuglio

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1755;
You have access
Peptide receptor radiotherapy (PRRT) as a potential tool of neoadjuvant therapy in patients with inoperable neuroendocrine tumors (NETs)
Anna Sowa-Staszczak, Dorota Pach, Agnieszka Stefanska, Monika Tomaszuk, Renata Mikolajczak, Dariusz Pawlak, Malgorzata Trofimiuk, Robert Chrzan and Alicja Hubalewska-Dydejczyk

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1743;
You have access
Characterization of 177Lu-Affibody-HSA bioconjugate for radionuclide therapy of EGFR-expressing head and neck carcinomas
Susan Hoppmann, Shibo Qi, Zheng Miao, Hongguang Liu, Han Jiang and Zhen Cheng

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1735;
You have access
Safety and efficacy of peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumor patients having single kidney or nonfunctional kidney
Vikas Prasad, Harshad Kulkarni, Carolin Zachert, Dieter Hoersch and Richard Baum

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1741;
You have access
Formulation of radioactive nanoparticles for therapy of neuroendocrine tumors: Encapsulation and in-vitro release kinetics
Geetanjali Arora, Jaya Shukla, Sourabh Ghosh, Arun Malhotra, Rakesh Kumar and Guru Bandopadhyaya

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1740;
You have access
Comparative therapeutic efficacy of 188Re-liposome and 5-FU in CT26-luc lung-metastatic mice model via intravenous route
Liang-Cheng Chen, Yu-Hsien Wu, I-Hshiang Liu, Chung Li Ho, Wan-Chi Lee, Chih-Hsien Chang, Keng-Li Lan, Gann Ting, Te-Wei Lee and Jui-Hung Shien

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1739;
You have access
Initial experience with tositumomab and iodine I 131 tositumomab for treatment of relapsed/refractory Hodgkin lymphoma
Heather Jacene, Yvette Kasamon, Richard Ambinder, Donna Serena, Wayne Kasecamp and Richard Wahl

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1757;
You have access
Samarium-153-DOTMP treatment of spontaneously-occurring bone cancer in dogs as a proof-of-concept model
Kim Selting, Jimmy Lattimer, Alan Ketring, Druce Crump, Jaime (Jim) Simon, R. Frank and Carolyn Henry

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1747;

Main menu

User menu

Search

More articles from Radiopharmaceutical Therapy Posters

Pages